| Blood p50 evaluation enhances diagnostic definition of isolated erythrocytosis E Rumi, F Passamonti, L Pagano, M Ammirabile, L Arcaini, C Elena, ... Journal of internal medicine 265 (2), 266-274, 2009 | 37 | 2009 |
| Combined chelation therapy in thalassemia major with deferiprone and desferrioxamine: a retrospective study P Ricchi, M Ammirabile, A Spasiano, S Costantini, P Cinque, T Di Matola, ... European journal of haematology 85 (1), 36-42, 2010 | 35 | 2010 |
| A useful relationship between the presence of extramedullary erythropoeisis and the level of the soluble form of the transferrin receptor in a large cohort of adult patients … P Ricchi, M Ammirabile, S Costantini, T Di Matola, R Verna, A Diano, ... Annals of hematology 91, 905-909, 2012 | 34 | 2012 |
| Hypocholesterolemia in adult patients with thalassemia: a link with the severity of genotype in thalassemia intermedia patients P Ricchi, M Ammirabile, A Spasiano, S Costantini, T Di Matola, P Cinque, ... European journal of haematology 82 (3), 219-222, 2009 | 34 | 2009 |
| Extramedullary haematopoiesis correlates with genotype and absence of cardiac iron overload in polytransfused adults with thalassaemia P Ricchi, M Ammirabile, A Spasiano, S Costantini, T Di Matola, A Pepe, ... Blood Transfusion 12 (Suppl 1), s124, 2014 | 26 | 2014 |
| Splenectomy is a risk factor for developing hyperuricemia and nephrolithiasis in patients with thalassemia intermedia: a retrospective study P Ricchi, M Ammirabile, S Costantini, T Di Matola, A Spasiano, ML Genna, ... Blood Cells, Molecules, and Diseases 49 (3-4), 133-135, 2012 | 24 | 2012 |
| The assessment of high sensitivity cardiac troponin in patients with COVID-19: A multicenter study MA Perrone, F Spolaore, M Ammirabile, F Romeo, P Caciagli, F Ceriotti, ... IJC Heart & Vasculature 32, 100715, 2021 | 23 | 2021 |
| HFE gene mutations in patients with acute leukemia A Viola, L Pagano, D Laudati, R D'elia, MR D'amico, M Ammirabile, ... Leukemia & lymphoma 47 (11), 2331-2334, 2006 | 22 | 2006 |
| Soluble form of transferrin receptor as a biomarker of overall morbidity in patients with non-transfusion-dependent thalassaemia: a cross-sectional study P Ricchi, M Ammirabile, S Costantini, A Spasiano, T Di Matola, R Verna, ... Blood Transfusion 14 (6), 538, 2016 | 19 | 2016 |
| Renal cell carcinoma in adult patients with thalassaemia major: a description of three cases P Ricchi, M Ammirabile, A Spasiano, S Costantini, T Di Matola, G Cartenì, ... British journal of haematology 165 (6), 887-888, 2014 | 17 | 2014 |
| Cell Population Data NE‐WX, NE‐FSC, LY‐Y of Sysmex XN‐9000 can provide additional information to differentiate macrocytic anaemia from myelodysplastic syndrome: A preliminary … D Di Luise, JA Giannotta, M Ammirabile, V De Zordi, S Torricelli, ... International journal of laboratory hematology 44 (1), 2022 | 15 | 2022 |
| The long-term and extensive efficacy of low dose thalidomide in a case of an untransfusable patient with non-transfusion-dependent thalassemia P Ricchi, S Costantini, A Spasiano, G De Dominicis, T Di Matola, ... Blood Cells, Molecules, and Diseases 57, 97-99, 2016 | 14 | 2016 |
| The impact of previous or concomitant IFN therapy on deferiprone-induced agranulocytosis and neutropenia: a retrospective study P Ricchi, M Ammirabile, S Costantini, P Cinque, AG Lanza, A Spasiano, ... Expert Opinion on Drug Safety 9 (6), 875-881, 2010 | 14 | 2010 |
| The effects of a 50 km ultramarathon race on high sensitivity cardiac troponin I and NT-proBNP in highly trained athletes. MA Perrone, M Macrini, A Maregnani, M Ammirabile, A Clerico, ... Minerva Cardioangiologica 68 (4), 305-312, 2020 | 12 | 2020 |
| Pelvic adhesion and gonadotropin-releasing hormone analogue: effects of triptorelin acetate depot on coagulation and fibrinolytic activities MA Di Nardo, ML Annunziata, M Ammirabile, MND Di Minno, AL Ruocco, ... Reproductive Sciences 19 (6), 615-622, 2012 | 12 | 2012 |
| Nephrolithiasis in patients exposed to deferasirox and desferioxamine: probably an age-linked event with different effects on some renal parameters P Ricchi, M Ammirabile, S Costantini, A Spasiano, T Di Matola, P Cinque, ... Annals of hematology 93, 525-527, 2014 | 11 | 2014 |
| Identification and molecular characterization of the--CAMPANIA deletion, a novel alpha zero-thalassemic defect, in two unrelated Italian families R Sessa, S Puzone, M Ammirabile, C Piscopo, L Pagano, S Colucci, ... American journal of hematology 85 (2), 143-144, 2010 | 11 | 2010 |
| Hypocholesterolaemia in thalassaemia–pathogenesis, implications and clinical effects P Ricchi, M Ammirabile, A Maggio TC (mg/dl) 106 (23), 74-24, 2010 | 11 | 2010 |
| Neapolis (CD 126 β+ GTG→ GGG): a result of a screening in Campania, a region in Southern Italy L Pagano, A Viola, G Fioretti, M Ammirabile, P Ricchi, L Prossomariti Haematologica 92 (7), 990-991, 2007 | 10 | 2007 |
| Predicting factors for liver iron overload at the first magnetic resonance in children with thalassaemia major M Casale, M Marsella, M Ammirabile, A Spasiano, S Costantini, P Cinque, ... Blood Transfusion 17 (3), 165, 2019 | 9 | 2019 |
Paolo RicchiMalattie Rare del Globulo Rosso, AORN Cardarelli, Napoli, Italia在 aocardarelli.it 的电子邮件经过验证
